Drug Profile
Esterified estrogens - GSK
Alternative Names: MenestLatest Information Update: 08 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Estradiol congeners; Hormonal replacements; Oral contraceptives
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome